TITLE

SECURITY IN REGISTRATION: EQUITY

PUB. DATE
August 2006
SOURCE
Investment Dealers' Digest;8/21/2006, Vol. 72 Issue 33, p30
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
A list of newly registered initial public offering by the Securities and Exchange Commission in the U.S. The corporate bodies include Vertex Pharmaceuticals, a biotechnology company, that is located in Cambridge, Massachusetts. Enterprise Products Partners, an oil and gas exploration production, in Houston, Texas and First Look Studios, motion picture production services, in Los Angeles, California.
ACCESSION #
22076796

 

Related Articles

  • IPO Window Widening for Biotech Firms.  // San Diego Business Journal;9/8/2003, Vol. 24 Issue 36, p9 

    Reports on the rise of initial public offerings (IPO) in biotechnology industry in the U.S. Number of biotech firms filed with the Securities and Exchange Commission to make the rite of passage from private start ups to public firms; Amount of stock sold by biotechnological companies filed for...

  • IPOs: the narrow window closes? Lawrence, Stacy // Nature Biotechnology;Dec2004, Vol. 22 Issue 12, p1489 

    The article discusses initial public offerings by biotechnology companies in the U.S. No biotech company has filed to go public on the U.S. markets in the fourth quarter as of mid-November 2004. And few filed in the previous quarter. In fact, most of the biotechs waiting in the wings to launch...

  • Conatus Pharma Seeks $69M For Liver Drug Emricasan. Powers, Marie // BioWorld Today;6/17/2013, Vol. 24 Issue 115, p1 

    The article offers information on the business growth of Conatus Pharmaceuticals Inc. It mentions regarding the company's effort for the development of liver drug emricasan after it received the global rights to the asset in its 2010 acquisition of Pfizer Inc. to become the latest biotechnology...

  • Portola Joins IPO Parade, Seeks $115M for Thrombosis Portfolio. Powers, Marie // BioWorld Today;4/16/2013, Vol. 24 Issue 72, p1 

    The article reports on Portola Pharmaceuticals Inc. filing of an S-1 with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO). Portola is described as the 12th biotechnology firm in 2013 and the third in the 2013 second quarter that seeks to move into the U.S....

  • Canada Welcomes SPACs. J. M. // Mergers & Acquisitions Report;1/5/2009, Vol. 22 Issue 1, p1 

    The article reports that Backlogged Special Purpose Acquisition Companies (SPAC) in Canada have been submitting filings to the Securities and Exchange Commission (SEC) increasingly requesting to have their initial public offerings (IPO) withdrawn. Kanders Acquisition, Builder Acquisition,...

  • SECURITIES IN REGISTRATION: EQUITY.  // Investment Dealers' Digest;3/14/2005, Vol. 71 Issue 10, p54 

    Presents a list of planned new initial public offering that have been registered with the U.S. Securities and Exchange Commission.

  • New IPOs scarce in Michigan. Henderson, Tom // Crain's Detroit Business;2/25/2008, Vol. 24 Issue 8, p2 

    The article reports that new initial public offerings (IPOs) in Michigan have plummeted in 2007. The U.S. Securities and Exchange Commission (SEC) notes that the Bloomfield-based TriMas Corp. was the only IPO in Michigan, which raised $139 million in May. According to the agency, there were a...

  • Amedica files for $75 million IPO; AM offer to raise more than $163M.  // Medical Device Daily;5/24/2007, Vol. 11 Issue 100, p1 

    The article reports that Amedica of Salt Lake City has filed a statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock valued at up to $74.75 million. All the offered shares will be sold by Amedica which plans to list its common stock...

  • CardioNet files with SEC, pricing 6.6M share IPO at $22 to $24.  // Cardiovascular Devices & Drugs;Mar2008, Vol. 14 Issue 3, p23 

    The article deals with the terms of the initial public officer (IPO) reported by CardioNet, a provider of real-time outpatient management solutions for monitoring an individual's cardiac health, in its U.S. Securities and Exchange Commission (SEC) filing. A total of 6.6 million shares will be...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics